… All modalities still represent clinically effective treatments and so provide alternative
options, … (first-line EVLA) and phlebectomies is suggested by this study to be the most cost-effective …

… catheters (Hickman), peripherally inserted central catheters (… systemic anticancer treatment
(SACT) via a central vein. We … acceptability, clinical effectiveness, and cost-effectiveness of …

… central venous catheters are widely used in clinical practice (3). In addition to delivering
chemotherapeutic drugs, central catheters … The cost-effectiveness acceptability curve shows that …

… of central venous catheters is better for cancer chemotherapy patients. In terms of costs,
practitioners need to make decisions about which type of central venous catheters has less cost. …

… venous catheter (PVC) is the most frequently used vascular device for infusion therapy, with
over 70% of inpatients requiring at least one catheterisation … or central venous catheter. …

… cost-effectiveness estimates, several deterministic sensitivity analyses were performed. To
explore the effect of … that the clinical effectiveness estimates are correct and can be replicated. …

… scarcity of evidence of clinical effectiveness or cost-effectiveness. We aimed to compare
the long-term clinical effectiveness and cost-effectiveness of levetiracetam compared with …

… as first-line treatments because of insufficient evidence of clinical effectiveness and cost-effectiveness…
We aimed to assess the long-term clinical effectiveness and cost-effectiveness of …

… of treatment effect remain uncertain since previous studies often give contradictory results.
The present study aims to investigate clinical effectiveness and cost-effectiveness … from clinical …

… central VADs both in adults and in pediatric patients; effectiveness, safety, and cost-effectiveness …
effectiveness, safety, and cost-effectiveness of SAS is still scarce, the Italian Group of …